in vivo News and Research

RSS

Panel of human antibodies developed to neutralize black mamba snake toxin

IONTAS Limited, a leader in the discovery and optimisation of fully human antibodies, today announced a collaborative paper published in Nature Communications with the Technical University of Denmark, and the Instituto Clodomiro Picado of the University of Costa Rica describing the development of a panel of human antibodies that neutralise elements of black mamba snake toxin in an in vivo model.

3 Oct 2018

Alnylam reports further progress on broadening the therapeutic potential of RNAi

Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced today further progress on the Company's platform efforts in extrahepatic delivery of novel siRNA conjugates, including central nervous system (CNS) and ocular delivery in rat and non-human primates (NHPs).

3 Oct 2018

TEAD1 protein appears to be important regulator of tumor migration in glioblastoma

A specific protein called TEAD1 is an important regulator of tumor migration in glioblastoma, the most common brain tumor in adults, and deactivating this protein may stop tumor cells from migrating away from the main tumor mass, according to research conducted at the Icahn School of Medicine at Mount Sinai and published October 1 in the journal Nature Communications.

1 Oct 2018

New tool provides improved in vivo imaging of atherosclerotic plaque development

Atherosclerosis, involving the buildup of plaque in the arteries and an associated reduction in the flow of blood, is a major feature of cardiovascular diseases.

28 Sep 2018

Researchers decipher antitumor mechanism of Amazonian plant in human cancer cells

A piece of research conducted by the Free Radicals and Oxidative Stress Group at the UPV/EHU's Faculty of Medicine and Nursing has deciphered the antitumor mechanism exerted by the plant Vismia baccifera, originally from the Amazonian region of Colombia, in human liver cancer cells.

28 Sep 2018

Axol's Human iPSC-derived Microglia for neuroimmunology research

Our Human iPSC-derived Microglia are suitable for a variety of applications including in vitro disease models, phenotypic screening and immunology studies.

From Axol Bioscience Ltd 27 Sep 2018

RTI Surgical showcases innovative spine portfolio at NASS 2018

RTI Surgical, Inc., a global surgical implant company, will showcase research reinforcing the strength of its spine portfolio, notably the Fortilink IBF series featuring TETRAfuse 3D Technology, at the North American Spine Society's 33rd Annual Meeting in Los Angeles, September 26-29.

26 Sep 2018

Exploring parallels between biological and computing world

RNA-based algorithms can advance cellular computing and enable new biological solutions for healthcare and industrial biotechnology.

26 Sep 2018

Toxicological evaluation and dosimetry estimation of potential PET radiotracer

The SR101 N-(3-[18F]Fluoropropyl) sulfonamide ([18F]SRF101) is a Sulforhodamine 101 derivative that was previously synthesized by our group.

25 Sep 2018

Hybrid theranostic complex shows high therapeutic efficacy against tumor cells

Emerging cancer nanotechnology enables target-delivery of substantial payloads of drugs to cancer sites with concomitant reduction of side-effects due to the lesser accumulation in the critical organs.

25 Sep 2018

Gene therapy approach could help treat mitochondrial diseases

Researchers have developed a genome-editing tool for the potential treatment of mitochondrial diseases: serious and often fatal conditions which affect 1 in 5,000 people.

24 Sep 2018

CSU chemists may help in making extracorporeal life support devices more effective

Smoke inhalation, pneumonia, and combat-related trauma are just a few causes of acute respiratory distress syndrome - a condition where the lungs fill with fluid, and is too often fatal.

24 Sep 2018

Researchers highlight potential therapy for treating rare, deadly blood-clotting disorder

In proof-of-concept experiments, University of Alabama at Birmingham researchers have highlighted a potential therapy for a rare but potentially deadly blood-clotting disorder, TTP.

24 Sep 2018

King's commemorates opening of new NMR facility with one-day symposium

On Tuesday 4 September the Nuclear Magnetic Resonance facility celebrated the refurbishment of their suite of spectrometers by hosting a one-day symposium.

24 Sep 2018

Researchers develop technology to study behavior of implants without animal testing

An international team of researchers consisting of scientists from NUST MISIS and TU Dortmund University has developed a technology to study the behavior of orthopedic implants in laboratory conditions as close as possible to the human body.

21 Sep 2018

Study reveals promising new drug candidate to treat acute renal failure

A protein produced by the human body appears to be a promising new drug candidate to treat conditions that lead to acute renal failure. This is shown by a study conducted at São Paulo State University in São José do Rio Preto, Brazil.

20 Sep 2018

Novel method achieves accurate and precise temperature estimation in fat-containing tissues

Magnetic resonance thermometry is the only imaging technique that noninvasively provides temperature distribution in vivo. The water proton resonance frequency shift -based method is the most popular choice for MR temperature monitoring in aqueous tissues.

20 Sep 2018

LineaRx signs agreement with Takis/Evvivax to develop linear-DNA based anti-cancer vaccines

Applied DNA Sciences Inc. announced today that LineaRx, Inc., its wholly-owned subsidiary focused on next-generation biotherapeutics, has signed a Joint Development Agreement with Takis S.R.L. and Evvivax S.R.L., biotechnology companies focused on the discovery and development of DNA based anti-cancer vaccines for the human and animal markets, respectively.

20 Sep 2018

MILabs' VECTor6 system wins Commercial Innovation Award at WMIC 2018

MILabs is pleased to announce that its new VECTor6 with Broadband Photon Tomography technique has received the Commercial Innovation Award at the World Molecular Imaging Congress (WMIC) in Seattle September 12th-15th, 2018.

20 Sep 2018

Scientists better understand influenza virus and how it spreads

The seasonal flu is caused by different subtypes of Influenza A virus and typically leads to the death of half a million people each year.

20 Sep 2018

in vivo News and Research

Panel of human antibodies developed to neutralize black mamba snake toxin

Alnylam reports further progress on broadening the therapeutic potential of RNAi

TEAD1 protein appears to be important regulator of tumor migration in glioblastoma

New tool provides improved in vivo imaging of atherosclerotic plaque development

Researchers decipher antitumor mechanism of Amazonian plant in human cancer cells

Axol's Human iPSC-derived Microglia for neuroimmunology research

RTI Surgical showcases innovative spine portfolio at NASS 2018

Exploring parallels between biological and computing world

Toxicological evaluation and dosimetry estimation of potential PET radiotracer

Hybrid theranostic complex shows high therapeutic efficacy against tumor cells

Gene therapy approach could help treat mitochondrial diseases

CSU chemists may help in making extracorporeal life support devices more effective

Researchers highlight potential therapy for treating rare, deadly blood-clotting disorder

King's commemorates opening of new NMR facility with one-day symposium

Researchers develop technology to study behavior of implants without animal testing

Study reveals promising new drug candidate to treat acute renal failure

Novel method achieves accurate and precise temperature estimation in fat-containing tissues

LineaRx signs agreement with Takis/Evvivax to develop linear-DNA based anti-cancer vaccines

MILabs' VECTor6 system wins Commercial Innovation Award at WMIC 2018

Scientists better understand influenza virus and how it spreads

eBook: Using iPSCs models for human disease research and drug discovery eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News